Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × camrelizumab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Rectal Cancer Patients 1 Locally Advanced Rectal Cancer 1 Esophageal Neoplasms 1

Interventions

Fluorouracil 9 Oxaliplatin 8 pembrolizumab 7 Leucovorin 7 Capecitabine 6 Cisplatin 5 Carboplatin 5 Nivolumab 4 Specimen Handling 3 Radiotherapy 3 Paclitaxel 3 Irinotecan 3 Esophagectomy 3 zanidatamab 2 trastuzumab deruxtecan 2 patritumab deruxtecan 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Surveys and Questionnaires 2 Radiotherapy, Intensity-Modulated 2 Proton Therapy 2 Magnetic Resonance Spectroscopy 2 Levoleucovorin 2 Immune Checkpoint Inhibitors 2 Drug Therapy 2 Biopsy 2 zolbetuximab 1 zimberelimab 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07530094 2026-04-15

STELLAR01

Jiangsu Cancer Institute & Hospital

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡